MedTrace Logo

Timed Aspirin Chronobiome Study

NCT03590821 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-23

No results posted yet for this study

Summary

To determine whether timed administration of aspirin ameliorates the effects of celecoxib on blood pressure.

Conditions

  • Healthy

Interventions

DRUG

Aspirin 81 mg

timed administration of aspirin in the evening

DRUG

Celecoxib 200mg capsule

daily administration of celecoxib

Sponsors & Collaborators

Principal Investigators

  • Carsten Skarke, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2027-12-31
Primary Completion
2028-01-31
Completion
2028-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03590821 on ClinicalTrials.gov